CEFUROXIME AXETIL Drug Patent Profile
✉ Email this page to a colleague
When do Cefuroxime Axetil patents expire, and when can generic versions of Cefuroxime Axetil launch?
Cefuroxime Axetil is a drug marketed by Sun Pharm Inds Ltd, Alkem Labs Ltd, Anda Repository, Ani Pharms, Apotex, Aurobindo Pharma, Chartwell Rx, Fosun Pharma, Lupin, and Ranbaxy Labs Ltd. and is included in eleven NDAs.
The generic ingredient in CEFUROXIME AXETIL is cefuroxime axetil. There are sixty-two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the cefuroxime axetil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefuroxime Axetil
A generic version of CEFUROXIME AXETIL was approved as cefuroxime axetil by APOTEX on October 2nd, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFUROXIME AXETIL?
- What are the global sales for CEFUROXIME AXETIL?
- What is Average Wholesale Price for CEFUROXIME AXETIL?
Summary for CEFUROXIME AXETIL
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Finished Product Suppliers / Packagers: | 15 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Clinical Trials: | 8 |
| Patent Applications: | 3,669 |
| Drug Prices: | Drug price information for CEFUROXIME AXETIL |
| DailyMed Link: | CEFUROXIME AXETIL at DailyMed |
See drug prices for CEFUROXIME AXETIL
Recent Clinical Trials for CEFUROXIME AXETIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| James Graham Brown Cancer Center | Early Phase 1 |
| Julio Ramirez | Early Phase 1 |
| University of Louisville | Early Phase 1 |
Pharmacology for CEFUROXIME AXETIL
| Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for CEFUROXIME AXETIL
US Patents and Regulatory Information for CEFUROXIME AXETIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | CEFUROXIME AXETIL | cefuroxime axetil | FOR SUSPENSION;ORAL | 065323-001 | Feb 5, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fosun Pharma | CEFUROXIME AXETIL | cefuroxime axetil | TABLET;ORAL | 065126-001 | Oct 28, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ranbaxy Labs Ltd | CEFUROXIME AXETIL | cefuroxime axetil | TABLET;ORAL | 065043-001 | Feb 15, 2002 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Anda Repository | CEFUROXIME AXETIL | cefuroxime axetil | TABLET;ORAL | 065359-003 | Feb 15, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alkem Labs Ltd | CEFUROXIME AXETIL | cefuroxime axetil | TABLET;ORAL | 065496-002 | Jun 7, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Aurobindo Pharma | CEFUROXIME AXETIL | cefuroxime axetil | TABLET;ORAL | 065308-001 | Mar 29, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Lupin | CEFUROXIME AXETIL | cefuroxime axetil | TABLET;ORAL | 065135-001 | Jul 25, 2003 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
